Kazutomi Kusano

1.1k total citations
46 papers, 902 citations indexed

About

Kazutomi Kusano is a scholar working on Pharmacology, Molecular Biology and Oncology. According to data from OpenAlex, Kazutomi Kusano has authored 46 papers receiving a total of 902 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pharmacology, 17 papers in Molecular Biology and 11 papers in Oncology. Recurrent topics in Kazutomi Kusano's work include Pharmacogenetics and Drug Metabolism (16 papers), Drug Transport and Resistance Mechanisms (8 papers) and Pharmacological Effects and Toxicity Studies (5 papers). Kazutomi Kusano is often cited by papers focused on Pharmacogenetics and Drug Metabolism (16 papers), Drug Transport and Resistance Mechanisms (8 papers) and Pharmacological Effects and Toxicity Studies (5 papers). Kazutomi Kusano collaborates with scholars based in Japan, United States and Sri Lanka. Kazutomi Kusano's co-authors include Yuji Mano, Tsutomu Yoshimura, Osamu Takenaka, Norio Kagawa, Kenji Kita, Tsuneo Omura, Masao Sakaguchi, Yasushi Yamazoe, Kiyoshi Nagata and Kazuko Inoue and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Journal of Pharmacology and Experimental Therapeutics and European Journal of Biochemistry.

In The Last Decade

Kazutomi Kusano

44 papers receiving 876 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kazutomi Kusano Japan	20	310	269	241	127	116	46	902
Takenori Takahata Japan	19	477 1.5×	223 0.8×	377 1.6×	112 0.9×	148 1.3×	50	1.3k
Venkatesh Pilla Reddy United States	19	325 1.0×	207 0.8×	305 1.3×	130 1.0×	93 0.8×	56	1.1k
Tomoyuki Ohe Japan	23	429 1.4×	225 0.8×	359 1.5×	204 1.6×	83 0.7×	61	1.3k
Ernesto Callegari United States	15	421 1.4×	396 1.5×	342 1.4×	158 1.2×	138 1.2×	29	1.3k
Nina Hanke Germany	20	299 1.0×	308 1.1×	193 0.8×	158 1.2×	119 1.0×	40	1.1k
Andria L. Del Tredici United States	14	191 0.6×	457 1.7×	109 0.5×	203 1.6×	105 0.9×	28	835
Punit H. Marathe United States	15	246 0.8×	158 0.6×	220 0.9×	96 0.8×	81 0.7×	31	854
Birk Poller Switzerland	20	337 1.1×	254 0.9×	684 2.8×	257 2.0×	86 0.7×	35	1.3k
John P. Umland United States	14	509 1.6×	161 0.6×	312 1.3×	115 0.9×	439 3.8×	17	1.2k
Yingjie Guo China	20	352 1.1×	317 1.2×	318 1.3×	230 1.8×	131 1.1×	39	957

Countries citing papers authored by Kazutomi Kusano

Since Specialization

Citations

This map shows the geographic impact of Kazutomi Kusano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kazutomi Kusano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kazutomi Kusano more than expected).

Fields of papers citing papers by Kazutomi Kusano

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kazutomi Kusano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kazutomi Kusano. The network helps show where Kazutomi Kusano may publish in the future.

Co-authorship network of co-authors of Kazutomi Kusano

This figure shows the co-authorship network connecting the top 25 collaborators of Kazutomi Kusano. A scholar is included among the top collaborators of Kazutomi Kusano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kazutomi Kusano. Kazutomi Kusano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Imai, Shunji, et al.. (2024). The Usefulness of Determining Plasma and Tissue Concentrations of Phosphorodiamidate Morpholino Oligonucleotides to Estimate Their Efficacy in Duchenne Muscular Dystrophy Patients. Drug Metabolism and Disposition. 52(9). 1029–1036.

Inoue, Kazuko, et al.. (2023). In Vitro Metabolism of 2-Methoxy-N-[3-[4-[3-methyl-4-[(6-methyl- 3-pyridinyl)oxy]anilino]-6-quinazolinyl]prop-2-enyl]acetamide (CP-724,714) by Aldehyde Oxidase and Predicting Its Percent Contribution Relative to CYP-Mediated Metabolism. Drug Metabolism and Disposition. 51(8). 962–969. 1 indexed citations

Imai, Shunji, et al.. (2023). Prediction of Human Pharmacokinetics of Phosphorodiamidate Morpholino Oligonucleotides in Duchenne Muscular Dystrophy Patients Using Viltolarsen. Drug Metabolism and Disposition. 51(10). 1428–1435. 5 indexed citations

SUGAWARA, Michiko, et al.. (2017). Eribulin shows high concentration and long retention in xenograft tumor tissues. Cancer Chemotherapy and Pharmacology. 80(2). 377–384. 11 indexed citations

Mano, Yuji, et al.. (2016). Simultaneous Determination of Donepezil and Its Three Metabolites in Human Plasma Using LC–MS-MS. Journal of Chromatographic Science. 54(8). 1328–1335. 6 indexed citations

Mano, Yuji, Osamu Takenaka, & Kazutomi Kusano. (2015). HPLC with fluorescence detection assay of perampanel, a novel AMPA receptor antagonist, in human plasma for clinical pharmacokinetic studies. Biomedical Chromatography. 29(10). 1589–1593. 22 indexed citations

Inoue, Kazuko, et al.. (2014). Oxidative Metabolic Pathway of Lenvatinib Mediated by Aldehyde Oxidase. Drug Metabolism and Disposition. 42(8). 1326–1333. 31 indexed citations

Mano, Yuji, Osamu Takenaka, & Kazutomi Kusano. (2014). High-performance liquid chromatography–tandem mass spectrometry method for the determination of perampanel, a novel α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor antagonist in human plasma. Journal of Pharmaceutical and Biomedical Analysis. 107. 56–62. 34 indexed citations

Takenaka, Osamu, et al.. (2013). Species Difference in the Mechanism of Nonlinear Pharmacokinetics of E2074, a Novel Sodium Channel Inhibitor, in Rats, Dogs, and Monkeys. Drug Metabolism and Disposition. 41(5). 1004–1011. 6 indexed citations

10.

Izumi, Saki, Yoshitane Nozaki, Takafumi Komori, et al.. (2013). Substrate-Dependent Inhibition of Organic Anion Transporting Polypeptide 1B1: Comparative Analysis with Prototypical Probe Substrates Estradiol-17β-Glucuronide, Estrone-3-Sulfate, and Sulfobromophthalein. Drug Metabolism and Disposition. 41(10). 1859–1866. 84 indexed citations

11.

SUGAWARA, Michiko, Kiyoshi Okamoto, Tadashi Kadowaki, et al.. (2009). Expressions of Cytochrome P450, UDP-Glucuronosyltranferase, and Transporter Genes in Monolayer Carcinoma Cells Change in Subcutaneous Tumors Grown As Xenografts in Immunodeficient Nude Mice. Drug Metabolism and Disposition. 38(3). 526–533. 6 indexed citations

12.

SUGAWARA, Michiko, Kiyoshi Okamoto, Tadashi Kadowaki, et al.. (2009). Inoculation of Human Tumor Cells Alters the Basal Expression but Not the Inducibility of Cytochrome P450 Enzymes in Tumor-Bearing Mouse Liver. Drug Metabolism and Disposition. 37(11). 2244–2254. 5 indexed citations

13.

Yoshinari, Kouichi, et al.. (2008). Omeprazole transactivates human CYP1A1 and CYP1A2 expression through the common regulatory region containing multiple xenobiotic-responsive elements. Biochemical Pharmacology. 76(1). 139–145. 54 indexed citations

14.

Kusano, Kazutomi, Norio Kagawa, Masao Sakaguchi, Tsuneo Omura, & Michael R. Waterman. (2001). Importance of a Proline-Rich Sequence in the Amino-Terminal Region for Correct Folding of Mitochondrial and Soluble Microbial P450S. The Journal of Biochemistry. 129(2). 271–277. 21 indexed citations

15.

Yamazaki, Kazuto, et al.. (1997). Radiation Hybrid Mapping of Human Arylacetamide Deacetylase (AADAC) Locus to Chromosome 3. Genomics. 44(2). 248–250. 5 indexed citations

16.

Kusano, Kazutomi, Shôzô Tanaka, Masaki Ueda, et al.. (1994). Development of Radioimmunoassay for the Novel Platelet Activating Factor Receptor Antagonist, E6123, and Its Application to Pharmacokinetics in Laboratory Animals.. Biological and Pharmaceutical Bulletin. 17(2). 334–339. 4 indexed citations

17.

Kusano, Kazutomi, et al.. (1993). Metabolic polymorphism of E6123 in rhesus monkey. Xenobiotica. 23(6). 599–608. 3 indexed citations

18.

Kusano, Kazutomi, Shôzô Tanaka, Yoshiro Abe, Satoshi Ida, & Teruaki YUZURIHA. (1993). Pharmacokinetics of a new thienodiazepine platelet activating factor receptor antagonist (E6123) in laboratory animals. Is there a metabolic polymorphism in the rhesus monkey?. Xenobiotica. 23(6). 589–598. 4 indexed citations

19.

Okano, K., et al.. (1991). Synthesis of ¹⁴C‐labelled (S)‐(+)‐6‐(2‐chlorophenyl)‐3‐cyclopropanecarbonyl‐8,11‐ dimethyl‐2,3,4,5‐tetrahydro‐8H‐pyrido[4′,3′:4,5]thieno[3,2‐f][1,2,4]triazolo[4,3‐a][1,4]diazepine (¹⁴C‐E6123). Journal of Labelled Compounds and Radiopharmaceuticals. 29(9). 1073–1077. 3 indexed citations

20.

Ida, Hiroyuki, Kazutomi Kusano, Hideaki Suzuki, T. Tokoro, & Y. Eto. (1990). Galactosylceramide and galactosylsphingosine loading studies in cultured skin fibroblasts in human and murine globoid cell leukodystrophy. Biochemical and Biophysical Research Communications. 166(2). 1053–1060. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact